Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV002524406 | SCV003481955 | pathogenic | not provided | 2022-04-07 | criteria provided, single submitter | clinical testing | For these reasons, this variant has been classified as Pathogenic. ClinVar contains an entry for this variant (Variation ID: 438062). This variant is also known as c.3213delC (p.Gly1072AspfsTer17). This premature translational stop signal has been observed in individual(s) with COL18A1-related conditions (PMID: 32581362). The frequency data for this variant in the population databases is considered unreliable, as metrics indicate poor data quality at this position in the gnomAD database. This sequence change creates a premature translational stop signal (p.Gly892Aspfs*17) in the COL18A1 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in COL18A1 are known to be pathogenic (PMID: 12415512, 25456301). |
NIHR Bioresource Rare Diseases, |
RCV000505075 | SCV000598894 | likely pathogenic | Retinal dystrophy | 2015-01-01 | no assertion criteria provided | research |